Suppr超能文献

在模拟运输条件下,无搅拌时比较使用 100%血浆或 65%血小板添加剂溶液 III/35%血浆保存的机采血小板的体外评估。

Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65% platelet additive solution III/35% plasma and including periods without agitation under simulated shipping conditions.

机构信息

American Red Cross Biomedical Services and Holland Laboratory, Rockville, Maryland 20855, USA.

出版信息

Transfusion. 2012 Apr;52(4):834-43. doi: 10.1111/j.1537-2995.2011.03390.x. Epub 2011 Oct 20.

Abstract

BACKGROUND

A comparative study evaluated the retention of apheresis platelet (A-PLT) in vitro properties prepared with PLT additive solution (PAS)-III or 100% plasma and stored with continuous agitation (CA) and without continuous agitation (WCA).

STUDY DESIGN AND METHODS

PLTs collected with the Amicus cell separator (Fenwal, Inc.) were utilized to prepare two matched components, each with approximately 4 × 10(11) PLTs. In the primary study, one component contained 65% PAS-III/35% plasma and the other 100% plasma. Four storage scenarios were used, one with CA and three with periods without agitation under simulated shipping conditions. In vitro assays were used early and after 5 days of storage.

RESULTS

pH levels after 5 days with CA were less with PAS-III components than 100% plasma components, with levels always above 6.6 in any component. With CA, a number of other variables were reduced even early during storage with PAS-III including morphology, extent of shape change, hypotonic stress response, adhesion, and aggregation. Storage WCA resulted in only a limited increase in the magnitude of the assay differences between PAS-III and 100% plasma components. Periods WCA did not reduce the pH below 6.6. The thromboelastograph variable associated with the strengthening of clots by PLTs was essentially comparable with PAS-III and plasma components throughout storage with CA or WCA.

CONCLUSION

The data indicate that a 100% plasma medium provides for better retention of specific in vitro PLT properties, with CA and WCA, although the clinical significance of these in vitro decrements due to PAS-III is unknown.

摘要

背景

一项对比研究评估了使用血小板添加剂溶液(PAS)-III 或 100%血浆制备的体外保存的富含血小板血浆(A-PLT)的保留情况,分别采用连续搅拌(CA)和无连续搅拌(WCA)两种方法。

研究设计和方法

使用 Amicus 细胞分离器(Fenwal,Inc.)采集的血小板制备了两个匹配的成分,每个成分中含有约 4×10(11)个血小板。在初步研究中,一个成分含有 65%PAS-III/35%血浆,另一个成分含有 100%血浆。使用了四种储存方案,一种是 CA,另外三种是在模拟运输条件下进行无搅拌的储存。在早期和储存 5 天后进行了体外检测。

结果

在 CA 条件下,储存 5 天后,含有 PAS-III 的成分的 pH 值比含有 100%血浆的成分低,但任何成分的 pH 值均始终高于 6.6。即使在储存早期,CA 条件下也有许多其他变量,如形态、变形程度、低渗应激反应、黏附性和聚集性,都随着 PAS-III 的使用而降低。WCA 储存仅导致 PAS-III 和 100%血浆成分之间的检测差异的幅度略有增加。WCA 储存不会使 pH 值降至 6.6 以下。在 CA 或 WCA 储存过程中,与血小板增强血栓弹性图变量相关的变量基本与 PAS-III 和血浆成分相当。

结论

数据表明,100%血浆介质在 CA 和 WCA 条件下,更有利于维持特定的体外血小板特性,尽管由于 PAS-III 导致的这些体外减少的临床意义尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验